These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 24308225)
1. Definition of acetylsalicylic acid resistance using whole blood impedance aggregometry in patients undergoing coronary artery surgery. Petricević M; Biocina B; Konosić S; Burcar I; Sirić F; Mihaljević MZ; Ivancan V; Svetina L; Gasparović H Coll Antropol; 2013 Sep; 37(3):833-9. PubMed ID: 24308225 [TBL] [Abstract][Full Text] [Related]
2. Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy. Petricevic M; Biocina B; Konosic S; Kopjar T; Kunac N; Gasparovic H Heart Vessels; 2013 Jan; 28(1):57-65. PubMed ID: 22203409 [TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery. Mengistu AM; Mayer J; Boldt J; Röhm KD; Suttner SW J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):42-7. PubMed ID: 20427204 [TBL] [Abstract][Full Text] [Related]
5. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related]
6. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469 [TBL] [Abstract][Full Text] [Related]
7. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry. Della Corte A; Bancone C; Spadafora A; Borrelli M; Galdieri N; Quintiliano SN; Bifulco O; De Feo M Eur J Cardiothorac Surg; 2017 Nov; 52(5):901-908. PubMed ID: 28977378 [TBL] [Abstract][Full Text] [Related]
8. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery. Petricevic M; Biocina B; Milicic D; Konosic S; Ivancan V; Milosevic M; Burcar I; Gasparovic H J Thromb Thrombolysis; 2013 Jan; 35(1):31-40. PubMed ID: 22926758 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor. Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G; Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085 [TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests. Kammerer I; Bach J; Saggau W; Isgro F Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867 [TBL] [Abstract][Full Text] [Related]
11. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819 [TBL] [Abstract][Full Text] [Related]
12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903 [TBL] [Abstract][Full Text] [Related]
13. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor. Barbieri L; Verdoia M; Pergolini P; Nardin M; Rolla R; Marino P; Bellomo G; Suryapranata H; De Luca G; Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):352-8. PubMed ID: 26857781 [TBL] [Abstract][Full Text] [Related]
14. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
16. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation. Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201 [TBL] [Abstract][Full Text] [Related]
17. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120 [TBL] [Abstract][Full Text] [Related]
18. Monitoring ASA and P2Y12-specific platelet inhibition--comparison of conventional (single) and multiple electrode aggregometry. Krüger JC; Meves SH; Kara K; Mügge A; Neubauer H Scand J Clin Lab Invest; 2014 Oct; 74(7):568-74. PubMed ID: 25296945 [TBL] [Abstract][Full Text] [Related]
19. The monitoring of antiaggregation effect of acetylsalicylic acid therapy by measuring serum thromboxane B2 in patients with coronary artery bypass grafting. Klasic A; Lakusic N; Gaspar L; Kruzliak P Blood Coagul Fibrinolysis; 2016 Jun; 27(4):370-3. PubMed ID: 26575493 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry. Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]